The Company has established (2016) itself as a leading player in the Cardio-Diabetes and CVD segment and has been able to develop a broad network in the market.
Arrient has been able to emerge as a preferred company for most of the Healthcare Professional. This distinction has been achieved by its commitment to quality, efficiency, flexibility and cost competitiveness. The Company with its strength in Quality Management System is geared up to meet all regulatory requirements / challenges in market.
Arrient is currently working towards creating its capability through its expansion and capacity enhancements to emerge as a leading player in the segment.